vs

Side-by-side financial comparison of HERC HOLDINGS INC (HRI) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $30.1M, roughly 1.2× HERC HOLDINGS INC). On growth, HERC HOLDINGS INC posted the faster year-over-year revenue change (629.3% vs -57.1%).

Herc Holdings Inc. is a leading North American equipment rental service provider. It offers rental assets including heavy construction machinery, power tools, temporary power and climate control systems, serving clients across construction, industrial, events, infrastructure and government segments, with operations across the U.S. and Canada.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

HRI vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.2× larger
ORGO
$37.2M
$30.1M
HRI
Growing faster (revenue YoY)
HRI
HRI
+686.3% gap
HRI
629.3%
-57.1%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HRI
HRI
ORGO
ORGO
Revenue
$30.1M
$37.2M
Net Profit
$-99.9M
Gross Margin
42.3%
30.8%
Operating Margin
-77.4%
-185.1%
Net Margin
-331.7%
Revenue YoY
629.3%
-57.1%
Net Profit YoY
-866.2%
EPS (diluted)
$-0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HRI
HRI
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$30.1M
$225.6M
Q3 25
$10.1M
$150.9M
Q2 25
$6.3M
$101.0M
Q1 25
$4.2M
$86.7M
Q4 24
$4.1M
$126.7M
Q3 24
$115.2M
Q2 24
$130.2M
Net Profit
HRI
HRI
ORGO
ORGO
Q1 26
Q4 25
$-99.9M
$43.7M
Q3 25
$-7.5M
$21.6M
Q2 25
$-10.8M
$-9.4M
Q1 25
$-14.1M
$-18.8M
Q4 24
$-10.3M
$7.7M
Q3 24
$12.3M
Q2 24
$-17.0M
Gross Margin
HRI
HRI
ORGO
ORGO
Q1 26
30.8%
Q4 25
42.3%
Q3 25
25.8%
Q2 25
53.1%
Q1 25
35.0%
72.6%
Q4 24
21.4%
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
HRI
HRI
ORGO
ORGO
Q1 26
-185.1%
Q4 25
-77.4%
28.1%
Q3 25
-153.5%
13.7%
Q2 25
-147.4%
-12.5%
Q1 25
-242.7%
-30.9%
Q4 24
-206.3%
8.1%
Q3 24
5.4%
Q2 24
-10.7%
Net Margin
HRI
HRI
ORGO
ORGO
Q1 26
Q4 25
-331.7%
19.4%
Q3 25
-74.1%
14.3%
Q2 25
-171.4%
-9.3%
Q1 25
-332.8%
-21.7%
Q4 24
-250.3%
6.1%
Q3 24
10.7%
Q2 24
-13.1%
EPS (diluted)
HRI
HRI
ORGO
ORGO
Q1 26
Q4 25
$-0.36
$0.31
Q3 25
$-0.03
$0.11
Q2 25
$-0.08
$-0.10
Q1 25
$-0.15
$-0.17
Q4 24
$-0.15
$0.05
Q3 24
$0.09
Q2 24
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HRI
HRI
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$550.7M
$91.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$437.8M
Total Assets
$1.1B
$520.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HRI
HRI
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$550.7M
$93.7M
Q3 25
$432.8M
$63.7M
Q2 25
$67.6M
$73.1M
Q1 25
$110.0M
Q4 24
$30.0M
$135.6M
Q3 24
$94.3M
Q2 24
$89.9M
Total Debt
HRI
HRI
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$300.0K
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
HRI
HRI
ORGO
ORGO
Q1 26
Q4 25
$437.8M
$300.1M
Q3 25
$486.1M
$255.1M
Q2 25
$90.8M
$233.2M
Q1 25
$26.1M
$242.9M
Q4 24
$16.6M
$262.9M
Q3 24
$278.5M
Q2 24
$263.5M
Total Assets
HRI
HRI
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$1.1B
$598.7M
Q3 25
$550.2M
$509.8M
Q2 25
$152.0M
$461.1M
Q1 25
$104.6M
$467.4M
Q4 24
$109.6M
$497.9M
Q3 24
$446.3M
Q2 24
$443.2M
Debt / Equity
HRI
HRI
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.02×
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HRI
HRI
ORGO
ORGO
Operating Cash FlowLast quarter
$-12.7M
Free Cash FlowOCF − Capex
$-14.3M
FCF MarginFCF / Revenue
-47.6%
Capex IntensityCapex / Revenue
5.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HRI
HRI
ORGO
ORGO
Q1 26
Q4 25
$-12.7M
$39.4M
Q3 25
$-11.0M
$3.1M
Q2 25
$-8.4M
$-32.9M
Q1 25
$-6.7M
$-19.9M
Q4 24
$-8.1M
$10.9M
Q3 24
$8.7M
Q2 24
$4.7M
Free Cash Flow
HRI
HRI
ORGO
ORGO
Q1 26
Q4 25
$-14.3M
$34.8M
Q3 25
$-11.1M
$844.0K
Q2 25
$-8.5M
$-36.5M
Q1 25
$-6.8M
$-23.6M
Q4 24
$-8.1M
$7.6M
Q3 24
$6.1M
Q2 24
$2.9M
FCF Margin
HRI
HRI
ORGO
ORGO
Q1 26
Q4 25
-47.6%
15.4%
Q3 25
-110.2%
0.6%
Q2 25
-135.5%
-36.1%
Q1 25
-160.8%
-27.2%
Q4 24
-197.1%
6.0%
Q3 24
5.3%
Q2 24
2.2%
Capex Intensity
HRI
HRI
ORGO
ORGO
Q1 26
Q4 25
5.3%
2.1%
Q3 25
1.7%
1.5%
Q2 25
1.5%
3.6%
Q1 25
4.0%
4.2%
Q4 24
0.7%
2.7%
Q3 24
2.2%
Q2 24
1.4%
Cash Conversion
HRI
HRI
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HRI
HRI

Sales Of New Equipment$9.0M30%
Sales Of Parts And Supplies$8.0M27%
Other$7.1M24%
Serviceand Other Revenue$6.0M20%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons